Most cited papers from Kiyatec (United States)

Kiyatec (United States)

What are the most cited papers from Kiyatec (United States)?

The most cited paper from Kiyatec (United States) is "Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer" (Milena Hornburg, Mélanie Desbois, Shan Lu et al., 2021), with 410 citations. Next come "The Effect of Sterilization on Silk Fibroin Biomaterial Properties" (101) and "Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer" (66).

Published TypeFieldAccess

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer Milena Hornburg, Mélanie Desbois, Shan Lu et al. · Cancer Cell Open access	6 May 2021	410
2	The Effect of Sterilization on Silk Fibroin Biomaterial Properties Jelena Rnjak‐Kovacina, Teresa M. DesRochers, Kelly A. Burke et al. · Macromolecular Bioscience Open access	11 Mar 2015	101
3	Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer Stephen Shuford et al. · Scientific Reports Open access	Aug 2019	66
4	A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies Shashikant Srivastava, Jotam G. Pasipanodya, Geetha Ramachandran et al. · EBioMedicine Open access	28 Feb 2016	48
5	A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma Megan R. Reed, A. Geoffrey Lyle, Annick De Loose et al. · Cells Open access	2 Dec 2021	29
6	PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures Kathryn M. Appleton, Ashley K. Elrod, Katy A. Lassahn et al. · Cancer Immunology Immunotherapy Open access	25 Jan 2021	28
7	Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay Stephen Shuford et al. · Neuro-Oncology Advances Open access	2021	27
8	Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma Aubrey Ledford et al. · Scientific Reports Open access	28 Aug 2024	8
9	The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado et al. · FEBS Letters Open access	19 Dec 2023	7
10	Macrophage incorporation into a 3D perfusion tri-culture model of human breast cancer Teresa M. DesRochers, Lillia M. Holmes, Lauren J. O’Donnell et al. · Journal for ImmunoTherapy of Cancer Open access	4 Nov 2015	6
11	Comparison of the Predictive Validity of Norton and Braden Scales in Determining the Risk of Pressure Injury in Elderly Patients İbrahim KİYAT, Ayfer Özbaş · Clinical Nurse Specialist	16 Apr 2024	3
12	SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States Tran B. Ngo et al. · medRxiv PreprintOpen access	11 Aug 2021	2
13	Mutational analysis of selected high-grade malignancies in a premenopausal gynecologic cancer population: a potential for targeted therapies? Lauren Pinckney, Justin Collins, Christine M. G. Schammel et al. · Applied cancer research/Applied Cancer Research Open access	13 Aug 2018	1
14	INNV-33. FUNCTIONAL EX VIVO TESTING PROSPECTIVELY IDENTIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS SENSITIVE TO TEMOZOLOMIDE TREATMENT IRRESPECTIVE OF MGMT METHYLATION STATUS Tessa M. DesRochers, Lindsay Lipinski, Ajay Prakash Abad et al. · Neuro-Oncology Open access	Nov 2022	0
15	323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma Megan R. Reed, A. Geoffrey Lyle, Annick De Loose et al. · Journal of Clinical and Translational Science Open access	Apr 2022	0
16	INNV-16. CLINICAL APPLICABILITY OF INDIVIDUALIZED DRUG RESPONSE PROFILING UTILIZING EX-VIVO TISSUE-DERIVED 3D CELL CULTURE ASSAYS IN HIGH-GRADE GLIOMA: A SINGLE INSTITUTION CASE SERIES USING 3D-PREDICT RESULTS Lindsay Lipinski, Ajay Prakash Abad, Laszlo L. Mechtler et al. · Neuro-Oncology Open access	Nov 2020	0
17	227 Using 3D spheroid cultures towards personalized ex vivo profiling of immune checkpoint inhibitor efficacy in melanoma and non-small cell lung cancer Kathryn M. Appleton, Katy A. Lassahn, Ashley K. Elrod et al. · Regular and Young Investigator Award Abstracts Conference paperOpen access	Nov 2020	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.